The proprietary technology licensed from
Anandia allows the modification of cannabinoid levels in cannabis
providing 22nd Century Group an exclusive competitive advantage in the
burgeoning area of cannabis biotechnology.
In brief, the proprietary technology allows for the (i) increase in the
production and content of all or certain subsets of cannabinoids in the
cannabis plant, (ii) elimination of cannabinoids in hemp varieties, and
(iii) modification of the cannabinoid profile (percentage content of
each cannabinoid to the total content of all cannabinoids) for the
production of unique cannabis plant varieties for the medical marijuana
industry....
No comments:
Post a Comment